Entry Instance

HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 829190,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/829190/?format=api",
    "text_counter": 259,
    "type": "speech",
    "speaker_name": "Murang’a CWR, JP",
    "speaker_title": "Hon. (Ms.) Sabina Chege",
    "speaker": {
        "id": 884,
        "legal_name": "Sabina Wanjiru Chege",
        "slug": "sabina-wanjiru-chege"
    },
    "content": " Hon. Temporary Deputy Chairlady, I beg to move: THAT, the Schedule to the Bill be amended - (c) in the proposed new section 3B- (i) by deleting the words “health products” appearing in the proposed new subsection (1) and substituting therefor the words “pharmaceutical products”; (ii) by deleting the words “health products” appearing in the proposed new subsection (2) and substituting therefor the words “pharmaceutical products”; (iii) by deleting the words “government and government agencies” appearing in the proposed new subsection (2)(a) and substituting therefor the words “national and county governments”; (iv) by deleting the proposed new subsection (3)(f) and substituting therefor the following new subsection− (f) establish or prescribe the different categories of pharmacy business and the scope of practice of persons registered or enrolled in terms of this Act, or the services or acts which shall for purposes of this Act be deemed to be services or acts specially pertaining to pharmacists or pharmaceutical technologists, and the conditions under which those services may be provided or the acts which may be performed;” (v) by deleting the word “private” appearing in the proposed new subsection (3)(h); The amendments are consequential in line with the previous ones where the Committee deleted the proposed definition of “health products” and subsequently introduced “pharmaceutical products”. Further, the amendment to Section 3(2)(a) seeks to give the board the functions of advising both levels of government as opposed to the provision in the Bill that limits the advisory role to the government and government agencies. The amendment further gives the board the function of prescribing the scope of practice of various levels within the pharmaceutical industry. The electronic version of the Official Hansard Report is for information purposes only. Acertified version of this Report can be obtained from the Hansard Editor."
}